235
Views
2
CrossRef citations to date
0
Altmetric
Critical Care

Can death unrelated to secondary causes be predicted in intubated comatose tricyclic antidepressant-poisoned patients?

, , &
Pages 379-384 | Received 10 Feb 2011, Accepted 06 May 2011, Published online: 08 Jul 2011

References

  • Boehnert MT, Lovejoy FH Jr. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med 1985; 313:474–479.
  • Caravati EM, Bossart PJ. Demographic and electrocardiographic factors associated with severe tricyclic antidepressant toxicity. J Toxicol Clin Toxicol 1991; 29:31–43.
  • Liebelt EL, Francis PD, Woolf AD. ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity. Ann Emerg Med 1995; 26:195–201.
  • Harrigan RA, Brady WJ. ECG abnormalities in tricyclic antidepressant ingestion. Am J Emerg Med 1999; 17:387–393.
  • Singh N, Singh HK, Khan IA. Serial electrocardiographic changes as a predictor of cardiovascular toxicity in acute tricyclic antidepressant overdose. Am J Ther 2002; 9:75–79.
  • Thanacoody HK, Thomas SH. Tricyclic antidepressant poisoning: cardiovascular toxicity. Toxicol Rev 2005; 24:205–214.
  • Emerman CL, Connors AF, Jr, Burma GM. Level of consciousness as a predictor of complications following tricyclic overdose. Ann Emerg Med 1987; 16:326–330.
  • Hultén BA, Adams R, Askenasi R, Dallos V, Dawling S, Volans G, Heath A. Predicting severity of tricyclic antidepressant overdose. J Toxicol Clin Toxicol 1992; 30:161–170.
  • Kelsey JL, Whittemore AS, Evans AS, Thompson WD. Methods in Observational Epidemiology. 2nd. New York: Oxford University Press; 1996: 332–334.
  • Blackman K, Brown SF, Wilkes GJ. Plasma alkalinization for tricyclic antidepressant toxicity: a systematic review. Emerg Med (Fremantle) 2001; 13:204–210.
  • Hoffman RS, Nelson LS, Howland MA, Lewin NA, Flomenbaum NE, Goldfrank LR. Goldfrank's Manual of Toxicologic Emergencies. New York: McGraw-Hill; 2007: 608–614.
  • Gilbert EH, Lowenstein SR, Koziol-McLain J, Barta DC, Steiner J. Chart reviews in emergency medicine research: where are the methods? Ann Emerg Med 1996; 27:305–308.
  • Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159–174.
  • Callaham M, Kassel D. Epidemiology of fatal tricyclic antidepressant ingestion: implications for management. Ann Emerg Med 1985; 14:1–9.
  • Bailey B, Buckley NA, Amre DK. A meta-analysis of prognostic indicators to predict seizures, arrhythmias or death after tricyclic antidepressant overdose. J Toxicol Clin Toxicol 2004; 42: 877–888.
  • Taboulet P. Cardiovascular complications of seizures during cyclic antidepressant poisoning. Reanimation Urgences 1997;6: 297–304.
  • Eyer F, Stenzel J, Schuster T, Felgenhauer N, Pfab R, von Bary C, Zilker T. Risk assessment of severe tricyclic antidepressant overdose. Hum Exp Toxicol 2009; 28:511–519.
  • Zaccara G, Muscas GC, Messori A. Clinical features, pathogenesis and management of drug-induced seizures. Drug Saf 1990; 5:109–151.
  • Lipper B, Bell A, Gaynor B. Recurrent hypotension immediately after seizures in nortriptyline overdose. Am J Emerg Med 1994; 12:452–453.
  • Ellison DW, Pentel PR. Clinical features and consequences of seizures due to cyclic antidepressant overdose. Am J Emerg Med 1989; 7:5–10.
  • Taboulet P, Michard F, Muszynski J, Galliot-Guilley M, Bismuth C. Cardiovascular repercussions of seizures during cyclic antidepressant poisoning. J Toxicol Clin Toxicol 1995; 33:205–211.
  • Fiedler VB, Martorana PA, Nitz RE. Protective actions of carbocromene against amitriptyline-induced cardiotoxicity in anesthetized rats. Arch Int Pharmacodyn Ther 1986; 279:103–120.
  • Wrenn K, Smith BA, Slovis CM. Profound alkalemia during treatment of tricyclic antidepressant overdose: a potential hazard of combined hyperventilation and intravenous bicarbonate. Am J Emerg Med 1992; 10:553–555.
  • Follmer CH, Lum BK. Protective action of diazepam and of sympathomimetic amines against amitryptyline-induced toxicity. J Pharmacol Exp Ther 1982; 222:424–429.
  • Goldgran-Toledano D, Sideris G, Kevorkian JP. Overdose of cyclic antidepressants and the Brugada syndrome. N Engl J Med 2002; 346:1591–1592.
  • Monteban-Kooistra WE, van den Berg MP, Tulleken JE, Ligtenberg JJ, Meertens JH, Zijlstra JG. Brugada electrocardiographic pattern elicited by cyclic antidepressants overdose. Intensive Care Med 2006; 32:281–285.
  • Bebarta VS, Phillips S, Eberhardt A, Calihan KJ, Waksman JC, Heard K. Incidence of Brugada electrocardiographic pattern and outcomes of these patients after intentional tricyclic antidepressant ingestion. Am J Cardiol 2007; 100:656–660.
  • Pellinen TJ, Färkkilä M, Heikkilä J, Luomanmäki K. Electrocardiographic and clinical features of tricyclic antidepressant intoxication. A survey of 88 cases and outlines of therapy. Ann Clin Res 1987; 19:12–17.
  • Olgun H, Yildirim ZK, Karacan M, Ceviz N. Clinical, electrocardiographic, and laboratory findings in children with amitriptyline intoxication. Pediatr Emerg Care 2009; 25:170–173.
  • Kitzlerová E, Paclt I, Slaviíček J. Antidepressants and their effect on the cardiovascular system. Ceska a Slovenska Psychiatrie 2002; 98:429–433.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.